Novel Drug From Neuro-Bio Effective in a Mouse Model of Alzh

NBP14 Targets Possible Primary Driver of Neurodegeneration Neuro-Bio Ltd, a biotechnology company developing a first-in-class treatment for neurodegen

Related Keywords

United Kingdom , London , City Of , Gregory Cole , Paull Herrling , Martin Rossor , King College London , Alzheimer Center , Global Head Of Research Novartis Pharma , Fbio Ltd , Professor Baroness Greenfield At Oxford University , Oxford University , Medicines Healthcare Products Regulatory Agency , Translational Research Clinical Interventions , Possible Primary Driver , Translational Research , Clinical Interventions , College London , Professor Susan Greenfield , Global Head , Novartis Pharma , Non Executive Director , Healthcare Products Regulatory Agency , Innovation Passport , Associate Director , Professor Baroness Greenfield , Neuro Bio Ltd ,